{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:10:07Z","timestamp":1752538207281,"version":"3.41.2"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,14]]},"DOI":"10.7759\/cureus.87935","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T23:48:00Z","timestamp":1752536880000},"source":"Crossref","is-referenced-by-count":0,"title":["Is Topiramate Helpful in the Management of Cocaine Use-Related Psychiatric Comorbidities?"],"prefix":"10.7759","author":[{"given":"Thayjas A","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo D","family":"Espiridion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M","family":"Napalinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration: Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (2024). Accessed: July 12, 2025: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42731\/2022-nsduh-nnr.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.036","article-title":"Health outcomes associated with crack-cocaine use: systematic review and meta-analyses","volume":"180","author":"Butler AJ","year":"2017","unstructured":"Butler AJ, Rehm J, Fischer B. Health outcomes associated with crack-cocaine use: systematic review and meta-analyses. Drug Alcohol Depend. 2017, 180:401-16. 10.1016\/j.drugalcdep.2017.08.036","journal-title":"Drug Alcohol Depend"},{"key":"ref3","unstructured":"Drug overdose deaths. facts and figures. (2024). Accessed: Dec 14, 2024: http:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates."},{"key":"ref4","article-title":"Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits","author":"Crane EH","year":"2013","unstructured":"Crane EH. Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. The CBHSQ Report. Substance Abuse and Mental Health Services Administration (US); 2013, Rockville, MD; 2013. 4:14-6."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton WM","year":"2007","unstructured":"Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007, 64:566-76. 10.1001\/archpsyc.64.5.566","journal-title":"Arch Gen Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.06.010","article-title":"Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence","volume":"92","author":"Crits-Christoph P","year":"2018","unstructured":"Crits-Christoph P, Wadden S, Gaines A, Rieger A, Gallop R, McKay JR, Gibbons MB. Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence. J Subst Abuse Treat. 2018, 92:46-50. 10.1016\/j.jsat.2018.06.010","journal-title":"J Subst Abuse Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1187-7","article-title":"Cocaine use may be associated with increased depression in persons infected with HIV","volume":"20","author":"Hammond ER","year":"2016","unstructured":"Hammond ER, Lai S, Wright CM, Treisman GJ. Cocaine use may be associated with increased depression in persons infected with HIV. AIDS Behav. 2016, 20:345-52. 10.1007\/s10461-015-1187-7","journal-title":"AIDS Behav"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway KP","year":"2006","unstructured":"Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006, 67:247-57. 10.4088\/jcp.v67n0211","journal-title":"J Clin Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.20882\/adicciones.124","article-title":"Psychopathological comorbidity in cocaine users in outpatient treatment (Article in Spanish)","volume":"26","author":"Araos P","year":"2014","unstructured":"Araos P, Vergara-Moragues E, Pedraz M, et al.. Psychopathological comorbidity in cocaine users in outpatient treatment (Article in Spanish). Adicciones. 2014, 26:15-26. 10.20882\/adicciones.124","journal-title":"Adicciones"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108933","article-title":"The relationship of frequency of cocaine use to substance and psychiatric disorders in the U.S. general population","volume":"227","author":"Aharonovich E","year":"2021","unstructured":"Aharonovich E, Scodes J, Wall MM, Hasin DS. The relationship of frequency of cocaine use to substance and psychiatric disorders in the U.S. general population. Drug Alcohol Depend. 2021, 227:108933. 10.1016\/j.drugalcdep.2021.108933","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.3.371","article-title":"Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period","volume":"149","author":"Marzuk PM","year":"1992","unstructured":"Marzuk PM, Tardiff K, Leon AC, Stajic M, Morgan EB, Mann JJ. Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry. 1992, 149:371-5. 10.1176\/ajp.149.3.371","journal-title":"Am J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.47626\/1516-4446-2021-2207","article-title":"Prevalence of suicide in cocaine users accessing health services: a systematic review and meta-analysis","volume":"44","author":"Mo\u00e7ambique M","year":"2022","unstructured":"Mo\u00e7ambique M, Hoffmann A, Roglio VS, Kessler FH, Dalbosco C, Schuch JB, Pechansky F. Prevalence of suicide in cocaine users accessing health services: a systematic review and meta-analysis. Braz J Psychiatry. 2022, 44:441-8. 10.47626\/1516-4446-2021-2207","journal-title":"Braz J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/092986712803988893","article-title":"Side effects of cocaine abuse: multiorgan toxicity and pathological consequences","volume":"19","author":"Riezzo I","year":"2012","unstructured":"Riezzo I, Fiore C, De Carlo D, Pascale N, Neri M, Turillazzi E, Fineschi V. Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr Med Chem. 2012, 19:5624-46. 10.2174\/092986712803988893","journal-title":"Curr Med Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"115","author":"Lopez-Quintero C","year":"2011","unstructured":"Lopez-Quintero C, P\u00e9rez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011, 115:120-30. 10.1016\/j.drugalcdep.2010.11.004","journal-title":"Drug Alcohol Depend"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz MC","year":"1987","unstructured":"Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987, 237:1219-23. 10.1126\/science.2820058","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000063258.68159.71","article-title":"Cocaine and the critical care challenge","volume":"31","author":"Shanti CM","year":"2003","unstructured":"Shanti CM, Lucas CE. Cocaine and the critical care challenge. Crit Care Med. 2003, 31:1851-9. 10.1097\/01.CCM.0000063258.68159.71","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890140210","article-title":"Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers","volume":"14","author":"Volkow ND","year":"1993","unstructured":"Volkow ND, Fowler JS, Wang GJ, et al.. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993, 14:169-77. 10.1002\/syn.890140210","journal-title":"Synapse"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas PW","year":"2005","unstructured":"Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005, 162:1403-13. 10.1176\/appi.ajp.162.8.1403","journal-title":"Am J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.51","article-title":"The neurocircuitry of addiction: an overview","volume":"154","author":"Feltenstein MW","year":"2008","unstructured":"Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol. 2008, 154:261-74. 10.1038\/bjp.2008.51","journal-title":"Br J Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-7634(99)00048-2","article-title":"Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology","volume":"24","author":"Gardner EL","year":"2000","unstructured":"Gardner EL, Ashby CR Jr. Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology. Neurosci Biobehav Rev. 2000, 24:115-8. 10.1016\/s0149-7634(99)00048-2","journal-title":"Neurosci Biobehav Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5","article-title":"Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine","volume":"34","author":"Gerasimov MR","year":"1999","unstructured":"Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD, Dewey SL. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse. 1999, 34:11-9. 10.1002\/(SICI)1098-2396(199910)34:1&lt;11::AID-SYN2&gt;3.0.CO;2-5","journal-title":"Synapse"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-10-03773.1992","article-title":"GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography","volume":"12","author":"Dewey SL","year":"1992","unstructured":"Dewey SL, Smith GS, Logan J, et al.. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci. 1992, 12:3773-80. 10.1523\/JNEUROSCI.12-10-03773.1992","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey SL","year":"1997","unstructured":"Dewey SL, Chaurasia CS, Chen CE, et al.. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse. 1997, 25:393-8. 10.1002\/(SICI)1098-2396(199704)25:4&lt;393::AID-SYN11&gt;3.0.CO;2-W","journal-title":"Synapse"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05144.x","article-title":"Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction","volume":"1187","author":"Schmidt HD","year":"2010","unstructured":"Schmidt HD, Pierce RC. Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci. 2010, 1187:35-75. 10.1111\/j.1749-6632.2009.05144.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2595","article-title":"Medication development in opioid addiction: meaningful clinical end points","volume":"10","author":"Volkow ND","year":"2018","unstructured":"Volkow ND, Woodcock J, Compton WM, Throckmorton DC, Skolnick P, Hertz S, Wargo EM. Medication development in opioid addiction: meaningful clinical end points. Sci Transl Med. 2018, 10:14-6. 10.1126\/scitranslmed.aan2595","journal-title":"Sci Transl Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins ST","year":"1994","unstructured":"Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994, 51:568-76. 10.1001\/archpsyc.1994.03950070060011","journal-title":"Arch Gen Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.9.817","article-title":"A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence","volume":"59","author":"Rawson RA","year":"2002","unstructured":"Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, Ling W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002, 59:817-24. 10.1001\/archpsyc.59.9.817","journal-title":"Arch Gen Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder-a systematic review and meta-analysis","volume":"34","author":"Chan B","year":"2019","unstructured":"Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder-a systematic review and meta-analysis. J Gen Intern Med. 2019, 34:2858-73. 10.1007\/s11606-019-05074-8","journal-title":"J Gen Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.2.627","article-title":"Topiramate increases cerebral GABA in healthy humans","volume":"51","author":"Kuzniecky R","year":"1998","unstructured":"Kuzniecky R, Hetherington H, Ho S, et al.. Topiramate increases cerebral GABA in healthy humans. Neurology. 1998, 51:627-9. 10.1212\/wnl.51.2.627","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.3.473","article-title":"Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy","volume":"52","author":"Petroff OA","year":"1999","unstructured":"Petroff OA, Hyder F, Mattson RH, Rothman DL. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology. 1999, 52:473-8. 10.1212\/wnl.52.3.473","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","article-title":"Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction","volume":"20","author":"Cornish JL","year":"2000","unstructured":"Cornish JL, Kalivas PW. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci. 2000, 20:RC89. 10.1523\/JNEUROSCI.20-15-j0006.2000","journal-title":"J Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)34966-3","article-title":"The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats","volume":"290","author":"Kushner SA","year":"1999","unstructured":"Kushner SA, Dewey SL, Kornetsky C. The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther. 1999, 290:797-802.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133x(96)00002-4","article-title":"Baclofen attenuates the reinforcing effects of cocaine in rats","volume":"15","author":"Roberts DC","year":"1996","unstructured":"Roberts DC, Andrews MM, Vickers GJ. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacol. 1996, 15:417-23. 10.1016\/0893-133x(96)00002-4","journal-title":"Neuropsychopharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction: a randomized clinical trial","volume":"70","author":"Johnson BA","year":"2013","unstructured":"Johnson BA, Ait-Daoud N, Wang XQ, Penberthy JK, Javors MA, Seneviratne C, Liu L. Topiramate for the treatment of cocaine addiction: a randomized clinical trial. JAMA Psychiatry. 2013, 70:1338-46. 10.1001\/jamapsychiatry.2013.2295","journal-title":"JAMA Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman KM","year":"2004","unstructured":"Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 2004, 75:233-40. 10.1016\/j.drugalcdep.2004.03.008","journal-title":"Drug Alcohol Depend"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(98)00110-4","article-title":"Use of topiramate, a new anti-epileptic as a mood stabilizer","volume":"50","author":"Marcotte D","year":"1998","unstructured":"Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord. 1998, 50:245-51. 10.1016\/s0165-0327(98)00110-4","journal-title":"J Affect Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00015","article-title":"A pilot study of topiramate as monotherapy in the treatment of acute mania","volume":"21","author":"Calabrese JR","year":"2001","unstructured":"Calabrese JR, Keck PE Jr, McElroy SL, Shelton MD. A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol. 2001, 21:340-2. 10.1097\/00004714-200106000-00015","journal-title":"J Clin Psychopharmacol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb05995.x","article-title":"Efficacy and adverse effects of established and new antiepileptic drugs","volume":"36","author":"Mattson RH","year":"1995","unstructured":"Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia. 1995, 36:S13-26. 10.1111\/j.1528-1157.1995.tb05995.x","journal-title":"Epilepsia"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050117","article-title":"The place of anticonvulsant therapy in bipolar illness","volume":"128","author":"Post RM","year":"1996","unstructured":"Post RM, Ketter TA, Denicoff K, et al.. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl). 1996, 128:115-29. 10.1007\/s002130050117","journal-title":"Psychopharmacology (Berl)"},{"key":"ref40","unstructured":"Publication guidelines. (2025). Accessed. June 29, 2025: https:\/\/trinetx.com\/real-world-resources\/case-studies-publications\/trinetx-publication-guidelines\/."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb K","year":"2010","unstructured":"Lieb K, V\u00f6llm B, R\u00fccker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010, 196:4-12. 10.1192\/bjp.bp.108.062984","journal-title":"Br J Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of topiramate for treatment of psychiatric disorders","volume":"4","author":"Arnone D","year":"2005","unstructured":"Arnone D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry. 2005, 4:5. 10.1186\/1744-859X-4-5","journal-title":"Ann Gen Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.04.003","article-title":"Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study","volume":"87","author":"Nickel C","year":"2005","unstructured":"Nickel C, Lahmann C, Tritt K, et al.. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study. J Affect Disord. 2005, 87:243-52. 10.1016\/j.jad.2005.04.003","journal-title":"J Affect Disord"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study","volume":"4","author":"McIntyre RS","year":"2002","unstructured":"McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord. 2002, 4:207-13. 10.1034\/j.1399-5618.2002.01189.x","journal-title":"Bipolar Disord"},{"key":"ref45","article-title":"Topiramate in treatment of refractory bipolar depression","volume":"6","author":"Hussain M","year":"2001","unstructured":"Hussain M, Chaudhry Z, Zubaida A, Hussain S. Topiramate in treatment of refractory bipolar depression. Eur Neuropsychopharmacol. 2001, 6:26-8.","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.01.016","article-title":"Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial","volume":"35","author":"Mowla A","year":"2011","unstructured":"Mowla A, Kardeh E. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35:970-3. 10.1016\/j.pnpbp.2011.01.016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00337-8","article-title":"Do obese depressed patients respond to topiramate? A retrospective chart review","volume":"69","author":"Carpenter LL","year":"2002","unstructured":"Carpenter LL, Leon Z, Yasmin S, Price LH. Do obese depressed patients respond to topiramate? A retrospective chart review. J Affect Disord. 2002, 69:251-5. 10.1016\/s0165-0327(01)00337-8","journal-title":"J Affect Disord"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.6.968a","article-title":"Mood stabilization and weight loss with topiramate","volume":"156","author":"Gordon A","year":"1999","unstructured":"Gordon A, Price LH. Mood stabilization and weight loss with topiramate. Am J Psychiatry. 1999, 156:968-9. 10.1176\/ajp.156.6.968a","journal-title":"Am J Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula M","year":"2007","unstructured":"Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007, 30:555-67. 10.2165\/00002018-200730070-00001","journal-title":"Drug Saf"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.2.321","article-title":"Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults","volume":"52","author":"Martin R","year":"1999","unstructured":"Martin R, Kuzniecky R, Ho S, et al.. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. 1999, 52:321-7. 10.1212\/wnl.52.2.321","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.05402.x","article-title":"Topiramate and psychiatric adverse events in patients with epilepsy","volume":"44","author":"Mula M","year":"2003","unstructured":"Mula M, Trimble MR, Lhatoo SD, Sander JW. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003, 44:659-63. 10.1046\/j.1528-1157.2003.05402.x","journal-title":"Epilepsia"},{"key":"ref52","unstructured":"Katz R. briefing document for the July 10, 2008 Advisory Committee to discuss antiepileptic drugs (AEDs) and suicidality. (2008). Accessed: July 12, 2025: https:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4372b1-01-FDA-Katz.pdf?utm_medium=email&amp;utm_source=transaction."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02012.x","article-title":"The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?","volume":"50","author":"Hesdorffer DC","year":"2009","unstructured":"Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?. Epilepsia. 2009, 50:978-86. 10.1111\/j.1528-1167.2009.02012.x","journal-title":"Epilepsia"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.4.682a","article-title":"Suicide attempt following initiation of topiramate","volume":"164","author":"Christman DS","year":"2007","unstructured":"Christman DS, Faubion MD. Suicide attempt following initiation of topiramate. Am J Psychiatry. 2007, 164:682-3. 10.1176\/ajp.2007.164.4.682a","journal-title":"Am J Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/070674370304800214","article-title":"Topiramate-induced suicidality","volume":"48","author":"Abraham G","year":"2003","unstructured":"Abraham G. Topiramate-induced suicidality. Can J Psychiatry. 2003, 48:127-8. 10.1177\/070674370304800214","journal-title":"Can J Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.159","article-title":"Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder","volume":"66","author":"Gibbons RD","year":"2009","unstructured":"Gibbons RD, Hur K, Brown CH, Mann JJ. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry. 2009, 66:1354-60. 10.1001\/archgenpsychiatry.2009.159","journal-title":"Arch Gen Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.410","article-title":"Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death","volume":"303","author":"Patorno E","year":"2010","unstructured":"Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010, 303:1401-9. 10.1001\/jama.2010.410","journal-title":"JAMA"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7511.2010.01382.x","article-title":"An update on antiepileptic drugs and suicide: are there definitive answers yet?","volume":"10","author":"Hesdorffer DC","year":"2010","unstructured":"Hesdorffer DC, Berg AT, Kanner AM. An update on antiepileptic drugs and suicide: are there definitive answers yet?. Epilepsy Curr. 2010, 10:137-45. 10.1111\/j.1535-7511.2010.01382.x","journal-title":"Epilepsy Curr"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00464.x","article-title":"Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide","volume":"10","author":"S\u00f8nderg\u00e5rd L","year":"2008","unstructured":"S\u00f8nderg\u00e5rd L, Lopez AG, Andersen PK, Kessing LV. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord. 2008, 10:87-94. 10.1111\/j.1399-5618.2008.00464.x","journal-title":"Bipolar Disord"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson BA","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, et al.. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003, 361:1677-85. 10.1016\/S0140-6736(03)13370-3","journal-title":"Lancet"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815473","article-title":"Effects of topiramate in the treatment of alcohol dependence","volume":"37","author":"Rubio G","year":"2004","unstructured":"Rubio G, Ponce G, Jim\u00e9nez-Arriero MA, Palomo T, Manzanares J, Ferre F. Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry. 2004, 37:37-40. 10.1055\/s-2004-815473","journal-title":"Pharmacopsychiatry"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181bfdb79","article-title":"Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence","volume":"29","author":"Rubio G","year":"2009","unstructured":"Rubio G, Mart\u00ednez-Gras I, Manzanares J. Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. J Clin Psychopharmacol. 2009, 29:584-9. 10.1097\/JCP.0b013e3181bfdb79","journal-title":"J Clin Psychopharmacol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2005.05.012","article-title":"Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse","volume":"52","author":"Huguelet P","year":"2005","unstructured":"Huguelet P, Morand-Collomb S. Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse. Pharmacol Res. 2005, 52:392-4. 10.1016\/j.phrs.2005.05.012","journal-title":"Pharmacol Res"},{"key":"ref64","article-title":"Topiramate as add-on therapy in non-respondent alcohol dependant patients: a 12 month follow-up study","volume":"35","author":"Fernandez Miranda JJ","year":"2007","unstructured":"Fernandez Miranda JJ, Marina Gonz\u00e1lez PA, Montes P\u00e9rez M, D\u00edaz Gonz\u00e1lez T, Gutierrez Cienfuegos E, Antu\u00f1a D\u00edaz MJ, Bobes Garc\u00eda J. Topiramate as add-on therapy in non-respondent alcohol dependant patients: a 12 month follow-up study. Actas Esp Psiquiatr. 2007, 35:236-42.","journal-title":"Actas Esp Psiquiatr"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson BA","year":"2007","unstructured":"Johnson BA, Rosenthal N, Capece JA, et al.. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007, 298:1641-51. 10.1001\/jama.298.14.1641","journal-title":"JAMA"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000228","article-title":"Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study","volume":"34","author":"Martinotti G","year":"2014","unstructured":"Martinotti G, Di Nicola M, De Vita O, et al.. Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study. J Clin Psychopharmacol. 2014, 34:709-15. 10.1097\/JCP.0000000000000228","journal-title":"J Clin Psychopharmacol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-41","article-title":"Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study","volume":"11","author":"Paparrigopoulos T","year":"2011","unstructured":"Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I. Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry. 2011, 11:41. 10.1186\/1471-244X-11-41","journal-title":"BMC Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.06.032","article-title":"Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial","volume":"133","author":"Likhitsathian S","year":"2013","unstructured":"Likhitsathian S, Uttawichai K, Booncharoen H, Wittayanookulluk A, Angkurawaranon C, Srisurapanont M. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. Drug Alcohol Depend. 2013, 133:440-6. 10.1016\/j.drugalcdep.2013.06.032","journal-title":"Drug Alcohol Depend"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.05.026","article-title":"A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence","volume":"133","author":"Kampman KM","year":"2013","unstructured":"Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend. 2013, 133:94-9. 10.1016\/j.drugalcdep.2013.05.026","journal-title":"Drug Alcohol Depend"},{"key":"ref70","article-title":"New-onset panic attacks associated with topiramate","volume":"3","author":"Christensen RC","year":"2006","unstructured":"Christensen RC, Garces LK. New-onset panic attacks associated with topiramate. Psychiatry (Edgmont). 2006, 3:10-8.","journal-title":"Psychiatry (Edgmont)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000118","article-title":"Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats","volume":"25","author":"Junqueira-Ayres DD","year":"2017","unstructured":"Junqueira-Ayres DD, Asth L, Ayres AS, Lob\u00e3o-Soares B, Soares-Rachetti VP, Gavioli EC. Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats. Exp Clin Psychopharmacol. 2017, 25:105-13. 10.1037\/pha0000118","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-4-24","article-title":"Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder","volume":"4","author":"Berlant JL","year":"2004","unstructured":"Berlant JL. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry. 2004, 4:24. 10.1186\/1471-244X-4-24","journal-title":"BMC Psychiatry"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n1213","article-title":"An open trial of topiramate in the treatment of generalized social phobia","volume":"65","author":"Van Ameringen M","year":"2004","unstructured":"Van Ameringen M, Mancini C, Pipe B, Oakman J, Bennett M. An open trial of topiramate in the treatment of generalized social phobia. J Clin Psychiatry. 2004, 65:1674-8. 10.4088\/jcp.v65n1213","journal-title":"J Clin Psychiatry"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders. A meta-analysis","volume":"170","author":"Harris EC","year":"1997","unstructured":"Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997, 170:205-28. 10.1192\/bjp.170.3.205","journal-title":"Br J Psychiatry"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900023269","article-title":"Suicide: clinical\/risk management issues for psychiatrists","volume":"5","author":"Jacobs DG","year":"2000","unstructured":"Jacobs DG, Jamison KR, Baldessarini RJ, Fawcett JA, Hendin H, Gutheil TG. Suicide: clinical\/risk management issues for psychiatrists. CNS Spectr. 2000, 5:32-55. 10.1017\/S1092852900023269","journal-title":"CNS Spectr"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn017","article-title":"Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003","volume":"167","author":"Haukka J","year":"2008","unstructured":"Haukka J, Suominen K, Partonen T, L\u00f6nnqvist J. Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003. Am J Epidemiol. 2008, 167:1155-63. 10.1093\/aje\/kwn017","journal-title":"Am J Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331227-is-topiramate-helpful-in-the-management-of-cocaine-use-related-psychiatric-comorbidities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T23:48:09Z","timestamp":1752536889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331227-is-topiramate-helpful-in-the-management-of-cocaine-use-related-psychiatric-comorbidities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":76,"URL":"https:\/\/doi.org\/10.7759\/cureus.87935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}